Non-psychotropic cannabinoid based therapy modulates nociceptive signaling molecules,
microglia, and pain behavior in a model of post-concussion headache
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Headache is a common symptom of post-concussion syndrome which may persist in a substantial portion of patients
contributing to a poor quality of life and disability. There is a pressing need to develop novel treatments for post-traumatic
headache as current treatments have a number of side effects, are contraindicated or lack efficacy. The Elliott laboratory
first established models of post-traumatic headache demonstrating sensitization of trigeminal neurons in rodent models of
post-traumatic headache using well-known nociceptive and behavioral markers in the pain and migraine fields1-3. Traumatic
brain injury in mice increases expression of calcitonin gene related peptide (CGRP) and inducible nitric oxide synthase
(iNOS) in the trigeminal pathway, changes that are accompanied by persistent headache behavior, trigeminal allodynia1-3.
The endogenous cannabinoid (eCB) system is a potential therapeutic target for post-traumatic headache. In a series of
studies, our laboratory showed CB2R-mediated anti-inflammatory actions in a model of TBI, whereby the reduction of iNOS
mRNA and protein and substance P immunoreactivity have implications for headache4-6. The cannabinoid receptor type-2
(CB2R) is an ideal analgesic target as it is devoid of psychoactive properties, shows anti-nociceptive actions upon
stimulation, and regulates immune function. What is unclear, is precisely how anti-nociceptive actions are elicited by the
CB2R, and if CB2R stimulation will be effective at alleviating trigeminal hypersensitivity in model of post-traumatic
concussion or closed head injury. The objective of this study was to determine the role of the CB2R in the trigeminal pain
pathway in a model of post-concussion headache, while identifying mechanisms underlying trigeminal pain after mild TBI.

Model of Traumatic Brain Injury Mild traumatic brain injury (TBI) was induced in Sprague Dawley rats utilizing a mild closed head injury
(CHI) injury model using a modified electromagnetic impactor device (Leica Biosystems Inc.). Animals were anesthetized with isoflurane
(3% induction; 2-2.5%) and had their body supported on a foam pad to prevent skull fracture. An incision was performed to expose the
calvarium and CHI was induced using a 10 mm diameter rubber tip at 5.0 mm depth, 5.0 m/sec at a 40° impact angle to the calvarium.
Controls received incision only without injury.
Experimental Design and Outcomes:
At 2 weeks after injury repeated CHI animals (rCHI) were treated two consecutive days with either vehicle control, a CB2 agonist (JWH133;
1 mg/kg), or an NSAID (Ketorolac; 0.4mg/kg). Sensory behavior indicative of headache, trigeminal allodynia was performed using von Frey
thresholds and photosensitivity testing1, 3, 5. Western blot experiments for proteins were then performed to examine expression of GFAP in
the right cortex (ipsilateral to injury). GAPDH protein was used as protein loading control. GFAP was measured using ELISA on serum
samples and reported as pg/mL. The effects of CHI were examined through immunohistochemistry labeling astrocytes (GFAP), calcitonin
receptor-like receptor, CRLR and inducible nitric oxide synthase (iNOS) in the trigeminal nucleus caudalis (TNC). In vitro brain slice
experiments were performed using 300µm slices of TNC and cerebrum. Brain slices were incubated with capsaicin, capsaicin + JWH133,
or media control solutions for 24hrs. The media was then collected and levels of CGRP and PGE2 were assessed with an ELISA.
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Figure 5: Inducible nitric oxide synthase (iNOS) immunoreacivity in the TNC. Inducible
NOS immunoreacivity for incision control (A), single CHI (B), and repeated CHIx3 (C). Noted
pattern of iNOS IR appears to be from trigeminal afferents and in the soma of second order
TNC neurons. Scale bar = 100µm
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Figure 1: Serum glial fibrillary acidic protein (GFAP). GFAP was measured
using enzyme linked immunosorbent assay for incision, single closed head
injured (CHI), and repeated (rCHI) rats. RCHI shows an increase in serum
GFAP levels compared to incision control, * p<0.05. n=6-7
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Figure 3: GFAP immunoreactivity in the TNC. GFAP immunoreactivity for
(A,D) Incision, (B,E) single CHI, and (C,F) repeated rCHI. Increases in GFAP
immunoreactivity can be seen in both CHI and rCHI when compared with
incision control. Scale bar = 100µm

Figure 4: Calcitonin receptor-like receptor,
CRLR, immunoreactivity in the TNC. CRLR for
(A-C) Incision control and (B-D) rCHIx2. Scale bar
= 20µm (A,B) and 50 µm (C,D).
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Figure 6: CGRP levels measured by ELISA for TNC brain slices. CGRP
levels from incision control and repeated CHI (rCHIx2) rats incubated with
media, capsaicin, or capsaicin + JWH133. (A) **p<0.01 repeated CHI vs.
Incision and single CHI, (B) **p<0.01 vs. media, (B) ###p<0.001 vs.
capsaicin .

Figure 8: Trigeminal allodynia thresholds (grams).
Trigeminal allodynia for rCHI rats treated with vehicle
control (n=8), JWH133 (5mg/kg) (n=4) and Ketorolac
(0.4mg/kg) (n=2). Dashed line represents allodynic
thresholds at ≤ 6g *p<0.05 and **p<0.01.	
  

§

Repeated CHI increased GFAP in the serum and ipsilateral cortex indicating
reactive gliosis. GFAP is currently one of the only utilized biomarkers for
patients with concussion.

§

Increased expression of GFAP and iNOS were observed within the trigeminal
pathway in a graded manner respective to the number of injuries and
concordant with previous findings in mild focal TBI.

§

CHI altered the calcitonin receptor-like receptor, CRLR, immunoreactivity in
the TNC in which a vascular and global response was noted.

§

Treatment with JWH133 showed a significant decrease in trigeminal allodynia,
similar to the NSAID, Ketolorac. Light testing showed changes in repeated
CHI compared to controls that were not seen in single CHI.

§

Repeated CHI injured rats showed increased capsaicin-induced CGRP in TNC
slices, while CHI did not result in a triggered CGRP increase over controls.

§

A CB2R agonist, JWH133, blocked capsaicin-induced increases in CGRP and
PGE2 in TNC and cerebrum slices incubated separately. CHI injured rats
showed increased capsaicin-induced PGE2 in cerebrum, but not TNC slices,
indicating potential for other pain mediators to be important in this pain region.

§

CB2R plays a role in the trigeminal nociceptive pathway, although the
mechanisms of analgesia will require more in depth investigation.
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Figure 2. Western blot GFAP expression. GFAP expression for the
ipsilateral somatosensory cortex of incision, single closed head
injured (CHI), and repeated (rCHIx3) rats. Analysis revealed
progressively increased GFAP in CHI (14.5%) and rCHI (48.3%) rats
on post-operated day 7 compared with controls; p < 0.05; n = 4-6).
Results demonstrate that the injury promotes gliosis in the sensory
cortex, which is a prominent marker for concussion.

Figure 7: PGE2 levels measured by ELISA for TNC and cerebrum brain
slices. PGE2 from incision control and repeated CHI rats incubated with media,
capsaicin, or capsaicin + JWH133. (A) Cerebrum slices **p<0.01 repeated CHI
vs. incision control; ##p<0.01, ###p<0.001 vs. capsaicin, (B) TNC slices
***p<0.001 vs. capsaicin.
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Figure 9: Photosensitivity testing
under ambient and bright light
conditions. Percentage of time in light
is shown at baseline control, single CHI
and repeated CHI rats.
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